Cooper Parry Corporate Finance advised the shareholders of Blink Medical on its acquisition by US-based, Private Equity backed, Katena Products – a worldwide leader in Ophthalmic products operating in 110 countries.
Blink Medical is the UK’s first supplier of single-use medical instruments in the ophthalmic surgical space. Blink’s product range has since expanded to include dermatology, ENT, cosmetic and plastic surgery. All instruments are inspected and packed in Blink’s own class-eight clean room in Solihull. Blink also export to over 20 countries. They supply NHS hospitals, private hospital groups and independent clinics.
The business has been acquired by Katena, in its first UK acquisition. The deal will give the new owners a platform in Europe for growth in both the UK and overseas and promises more jobs and further investment. Blink Medical Shareholder, Roger Tyler, will remain in the business.
Our Corporate Finance Partner, Andy Parker, acted as the lead adviser to the Shareholders on the deal. This is another deal that we’ve completed with US trade in the last 12 months, following on from the sale of eTech to CoreLogic Inc.
What people said
Roger Tyler, Founder and Managing Director of Blink Medical, said:
“The synergies created in the ophthalmic sector, by offering multiple instrument solutions to our customers will help both companies achieve their business objectives.”
Andy Parker, Head of Cooper Parry Corporate Finance, said:
“Medical Products is a sector that is generating a lot of interest. It was good to work with the investors in Katena, Audax Private Equity based in the US. There remains to be a lot of money in private equity, and we’re seeing more and more buy and build opportunities in the sector.”
Mark J Fletcher, CEO at Katina, said:
“The acquisition of Blink Medical strengthens and expands Katena’s offering in high quality ophthalmic instrumentation. Single-use instruments are important to our strategy and the addition of Blink also offers Katena the benefits of a physical presence in Europe.”